22 filings
S-8
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Registration of securities for employees
4:34pm
S-8
NMRA
Neumora Therapeutics Inc.
19 Sep 23
Registration of securities for employees
9:57pm
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
8-A12B
NMRA
Neumora Therapeutics Inc.
13 Sep 23
Registration of securities on exchange
5:00pm
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
S-1
m3kmbi
25 Aug 23
IPO registration
5:03pm
DRS/A
8yb0q6p
9 Aug 23
Draft registration statement (amended)
12:00am
DRSLTR
k9a81lw p65sh9y3
8 Aug 23
Correspondence regarding draft registration statement
12:00am
DRS/A
sphjcdhf
30 Jun 23
Draft registration statement (amended)
12:00am
DRSLTR
qtdxs gmq
30 Jun 23
Correspondence regarding draft registration statement
12:00am
DRS/A
v0ra0n9gzp 9ht
2 May 23
Draft registration statement (amended)
12:00am
D
cw4j cxyy
3 Jan 23
$474.36 mm in equity / securities to be acquired, sold $474.36 mm, 124 investors
2:40pm
DRS/A
xgnmykbx5z6mrgftx
2 Sep 22
Draft registration statement (amended)
12:00am
DRSLTR
bc54f6zxuholzcefga
2 Sep 22
Correspondence regarding draft registration statement
12:00am
DRS/A
tzfdn
10 Jun 22
Draft registration statement (amended)
12:00am
DRSLTR
uwpk6h
10 Jun 22
Correspondence regarding draft registration statement
12:00am
DRS/A
grgs1r thh9
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
lrk9k2g
14 Feb 22
Draft registration statement (amended)
12:00am
DRSLTR
fj65l q7r
11 Feb 22
Correspondence regarding draft registration statement
12:00am
DRS/A
ic2rua311dwyz erjzi
23 Dec 21
Draft registration statement (amended)
12:00am